Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors

Andrew Leone; Brant Inman; Philippe E Spiess

doi:10.1016/j.eururo.2017.01.024

Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors

Eur Urol. 2017 Jul;72(1):4-6. doi: 10.1016/j.eururo.2017.01.024. Epub 2017 Jan 26.

Authors

Andrew Leone¹, Brant Inman², Philippe E Spiess³

Affiliations

¹ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
² Duke Cancer Institute, Duke University, Durham, NC, USA.
³ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: [email protected].

PMID: 28131464
DOI: 10.1016/j.eururo.2017.01.024

Abstract

Laser ablation for low-risk primary penile tumors (Ta, Tis, and T1, preferably of low grade) offers satisfactory oncologic outcomes and excellent functional outcomes. Patients require long-term close surveillance given the substantial likelihood of local recurrence, and must adhere to strict follow-up protocols.

Publication types

Editorial
Review

MeSH terms

Consensus
Evidence-Based Medicine*
Humans
Laser Therapy / adverse effects
Laser Therapy / instrumentation*
Lasers / adverse effects
Male
Neoplasm Invasiveness
Penile Neoplasms / pathology
Penile Neoplasms / surgery*
Risk Factors
Time Factors
Treatment Outcome